ATE143009T1 - Neue heterocyclische carbonsäuren - Google Patents

Neue heterocyclische carbonsäuren

Info

Publication number
ATE143009T1
ATE143009T1 AT92910899T AT92910899T ATE143009T1 AT E143009 T1 ATE143009 T1 AT E143009T1 AT 92910899 T AT92910899 T AT 92910899T AT 92910899 T AT92910899 T AT 92910899T AT E143009 T1 ATE143009 T1 AT E143009T1
Authority
AT
Austria
Prior art keywords
carboxylic acids
heterocyclic carboxylic
new heterocyclic
compounds
new
Prior art date
Application number
AT92910899T
Other languages
English (en)
Inventor
Knud Erik Andersen
Lars Jacob Stray Knutsen
Per Olav Soerensen
Behrend Friedrich Lundt
Jesper Lau
Hans Petersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE143009T1 publication Critical patent/ATE143009T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT92910899T 1991-05-17 1992-05-14 Neue heterocyclische carbonsäuren ATE143009T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer

Publications (1)

Publication Number Publication Date
ATE143009T1 true ATE143009T1 (de) 1996-10-15

Family

ID=8099201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910899T ATE143009T1 (de) 1991-05-17 1992-05-14 Neue heterocyclische carbonsäuren

Country Status (16)

Country Link
US (1) US5348965A (de)
EP (1) EP0585314B1 (de)
JP (1) JPH06507616A (de)
AT (1) ATE143009T1 (de)
AU (1) AU665761B2 (de)
CA (1) CA2102811A1 (de)
DE (1) DE69213935T2 (de)
DK (2) DK93791D0 (de)
ES (1) ES2094357T3 (de)
FI (1) FI103116B (de)
GR (1) GR3021822T3 (de)
IL (1) IL101887A (de)
NO (1) NO300211B1 (de)
NZ (1) NZ242759A (de)
WO (1) WO1992020658A1 (de)
ZA (1) ZA923556B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74393D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74493D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
IL112223A0 (en) * 1994-01-04 1995-03-30 Novo Nordisk As Pharmaceutical compositions for the treatment of neurological inflammatory conditions
US5698551A (en) * 1995-04-07 1997-12-16 Novo Nordisk A/S Heterocyclic compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
AU1138397A (en) * 1995-12-15 1997-07-14 Novo Nordisk A/S Novel method
AU7907298A (en) * 1997-06-25 1999-01-19 Novo Nordisk A/S Novel heterocyclic compounds
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
US6468996B1 (en) * 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ-氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99690C (de) * 1956-11-15
BE560750A (de) * 1957-07-26
CH368178A (de) * 1958-09-10 1963-03-31 Geigy Ag J R Verfahren zur Herstellung von neuen basisch substituierten heterocyclischen Verbindungen
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
FI864246A7 (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer

Also Published As

Publication number Publication date
NO934159L (no) 1993-11-17
IL101887A0 (en) 1992-12-30
FI935064A0 (fi) 1993-11-16
EP0585314B1 (de) 1996-09-18
FI103116B1 (fi) 1999-04-30
NO934159D0 (no) 1993-11-17
DE69213935T2 (de) 1997-03-27
IL101887A (en) 1996-10-16
FI103116B (fi) 1999-04-30
WO1992020658A1 (en) 1992-11-26
FI935064L (fi) 1993-11-16
DE69213935D1 (en) 1996-10-24
EP0585314A1 (de) 1994-03-09
NO300211B1 (no) 1997-04-28
AU665761B2 (en) 1996-01-18
ES2094357T3 (es) 1997-01-16
ZA923556B (en) 1993-01-27
CA2102811A1 (en) 1992-11-26
GR3021822T3 (en) 1997-02-28
DK0585314T3 (de) 1997-05-05
DK93791D0 (da) 1991-05-17
AU1783792A (en) 1992-12-30
US5348965A (en) 1994-09-20
JPH06507616A (ja) 1994-09-01
NZ242759A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
NO934159L (no) Nye heterosykliske karboksylsyrer
EP0594285A3 (de) Aminosäure-funktionilasierte Siloxane.
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
IL103622A (en) Heteroarylpiperidines pyrrolidines and piperazines and antipsychotic and analgetic pharmaceutical compositions containing them
ATE306473T1 (de) Neue piperazinyl-substituierte pyridylalkan, alken and alkin carboxamide
FR2677019B1 (fr) Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
MX9304787A (es) Prodrogas de acidos de imidazolcarboxilicos y composiciones farmaceuticasque las contienen.
DE59308292D1 (de) Substituierte triole
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DE69830450D1 (de) Neue Atropisomere von 2,3-Disubstituierten-(5,6)-heteroarylkondensierten-pyrimidin-4-onen
MX9301707A (es) Composicion farmaceutica par inducir inmunosupresion.
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
FI954614A0 (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
FI923968A0 (fi) Heterocykliskt substituerade kinolylmetoxifenylacetamider.
ATE140228T1 (de) Hydroxymethyl-indolizidine und -chinolizidine
FR2672888B1 (fr) Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
FR2663631B1 (fr) Procede d'esterification des acides hydroxybenzoiques.
IT1224250B (it) Associzione del depiprazolo con la morfina
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
RU93046328A (ru) Инъекционное средство для гемокоррекции
FR2370053A1 (fr) Acides 7-acylamino-3-(1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl)-3-cepheme-4-carboxyliques et leur application en therapeutique
WO1997019669A3 (en) Heterocyclic compounds and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee